Literature DB >> 5662056

Fenfluramine metabolism.

R B Bruce, W R Maynard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5662056     DOI： 10.1002/jps.2600570717

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  9 in total

1.  Dreaming, fenfluramine, and vitamin C.

Authors:  A Mullen; C W Wilson; B P Wilson
Journal:  Br Med J       Date:  1977-01-08

2.  Treatment of obesity with fenfluramine.

Authors:  I Persson; U Andersen; T Deckert
Journal:  Eur J Clin Pharmacol       Date:  1973-08       Impact factor: 2.953

3.  Effect of long-term fenfluramine treatment on drug-metabolism in rat.

Authors:  P Arvela; N T Kärki; L Nieminen; K Bjondahl; M Möttönen
Journal:  Experientia       Date:  1973-04-15

4.  Kinetics of fenfluramine isomers in the rat.

Authors:  S Caccia; G Dagnino; S Garattini; G Guiso; R Madonna; M G Zanini
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

5.  Interactions of iprindole with fenfluramine metabolism in rat brain and liver.

Authors:  K M Hegadoren; G B Baker; R T Coutts; W G Dewhurst
Journal:  J Psychiatry Neurosci       Date:  1991-03       Impact factor: 6.186

Review 6.  In vitro evaluation of fenfluramine and norfenfluramine as victims of drug interactions.

Authors:  Parthena Martin; Maciej Czerwiński; Pallavi B Limaye; Seema Muranjan; Brian W Ogilvie; Steven Smith; Brooks Boyd
Journal:  Pharmacol Res Perspect       Date:  2022-06

Review 7.  Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

8.  Pharmacokinetics of fenfluramine enantiomers in man.

Authors:  S Caccia; M Ballabio; P De Ponte
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

9.  Pharmacokinetics of fenfluramine and norfenfluramine in volunteers given D- and DL-fenfluramine for 15 days.

Authors:  S Caccia; I Conforti; J Duchier; S Garattini
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.